These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 26589846

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Propofol facilitates cisplatin sensitivity via lncRNA MALAT1/miR-30e/ATG5 axis through suppressing autophagy in gastric cancer.
    Zhang YF, Li CS, Zhou Y, Lu XH.
    Life Sci; 2020 Mar 01; 244():117280. PubMed ID: 31926239
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines.
    Zhu W, Shan X, Wang T, Shu Y, Liu P.
    Int J Cancer; 2010 Dec 01; 127(11):2520-9. PubMed ID: 20162574
    [Abstract] [Full Text] [Related]

  • 6. miR-149 reverses cisplatin resistance of gastric cancer SGC7901/DDP cells by targeting FoxM1.
    Li X, Liang J, Liu YX, Wang Y, Yang XH, Luan BH, Zhang GL, Du J, Wu XH.
    Pharmazie; 2016 Nov 02; 71(11):640-643. PubMed ID: 29441968
    [Abstract] [Full Text] [Related]

  • 7. MiR-181a mediates Ang II-induced myocardial hypertrophy by mediating autophagy.
    Li AL, Lv JB, Gao L.
    Eur Rev Med Pharmacol Sci; 2017 Dec 02; 21(23):5462-5470. PubMed ID: 29243791
    [Abstract] [Full Text] [Related]

  • 8. PCAT-1 contributes to cisplatin resistance in gastric cancer through miR-128/ZEB1 axis.
    Guo Y, Yue P, Wang Y, Chen G, Li Y.
    Biomed Pharmacother; 2019 Oct 02; 118():109255. PubMed ID: 31352238
    [Abstract] [Full Text] [Related]

  • 9. Circular RNA MCTP2 inhibits cisplatin resistance in gastric cancer by miR-99a-5p-mediated induction of MTMR3 expression.
    Sun G, Li Z, He Z, Wang W, Wang S, Zhang X, Cao J, Xu P, Wang H, Huang X, Xia Y, Lv J, Xuan Z, Jiang T, Fang L, Yang J, Zhang D, Xu H, Xu Z.
    J Exp Clin Cancer Res; 2020 Nov 17; 39(1):246. PubMed ID: 33198772
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. MiR-223 promotes the cisplatin resistance of human gastric cancer cells via regulating cell cycle by targeting FBXW7.
    Zhou X, Jin W, Jia H, Yan J, Zhang G.
    J Exp Clin Cancer Res; 2015 Mar 26; 34(1):28. PubMed ID: 25888377
    [Abstract] [Full Text] [Related]

  • 12. MiR-129 regulates cisplatin-resistance in human gastric cancer cells by targeting P-gp.
    Lu C, Shan Z, Li C, Yang L.
    Biomed Pharmacother; 2017 Feb 26; 86():450-456. PubMed ID: 28012924
    [Abstract] [Full Text] [Related]

  • 13. LncRNA MALAT1 potentiates autophagy‑associated cisplatin resistance by regulating the microRNA‑30b/autophagy‑related gene 5 axis in gastric cancer.
    Xi Z, Si J, Nan J.
    Int J Oncol; 2019 Jan 26; 54(1):239-248. PubMed ID: 30365113
    [Abstract] [Full Text] [Related]

  • 14. Let-7b attenuates cisplatin resistance and tumor growth in gastric cancer by targeting AURKB.
    Han X, Zhang JJ, Han ZQ, Zhang HB, Wang ZA.
    Cancer Gene Ther; 2018 Dec 26; 25(11-12):300-308. PubMed ID: 30237418
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA-143 enhances chemosensitivity of Quercetin through autophagy inhibition via target GABARAPL1 in gastric cancer cells.
    Du F, Feng Y, Fang J, Yang M.
    Biomed Pharmacother; 2015 Aug 26; 74():169-77. PubMed ID: 26349981
    [Abstract] [Full Text] [Related]

  • 16. Down-regulation of CASC2 contributes to cisplatin resistance in gastric cancer by sponging miR-19a.
    Li Y, Lv S, Ning H, Li K, Zhou X, Xv H, Wen H.
    Biomed Pharmacother; 2018 Dec 26; 108():1775-1782. PubMed ID: 30372881
    [Abstract] [Full Text] [Related]

  • 17. Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells.
    Zheng P, Chen L, Yuan X, Luo Q, Liu Y, Xie G, Ma Y, Shen L.
    J Exp Clin Cancer Res; 2017 Apr 13; 36(1):53. PubMed ID: 28407783
    [Abstract] [Full Text] [Related]

  • 18. miR‑138‑5p modulates the expression of excision repair cross‑complementing proteins ERCC1 and ERCC4, and regulates the sensitivity of gastric cancer cells to cisplatin.
    Ning J, Jiao Y, Xie X, Deng X, Zhang Y, Yang Y, Zhao C, Wang H, Gu K.
    Oncol Rep; 2019 Feb 13; 41(2):1131-1139. PubMed ID: 30535472
    [Abstract] [Full Text] [Related]

  • 19. Upregulation of microRNA-34a enhances the DDP sensitivity of gastric cancer cells by modulating proliferation and apoptosis via targeting MET.
    Zhang Z, Kong Y, Yang W, Ma F, Zhang Y, Ji S, Ma EM, Liu H, Chen Y, Hua Y.
    Oncol Rep; 2016 Oct 13; 36(4):2391-7. PubMed ID: 27513895
    [Abstract] [Full Text] [Related]

  • 20. Involvement of miR-143 in cisplatin resistance of gastric cancer cells via targeting IGF1R and BCL2.
    Zhuang M, Shi Q, Zhang X, Ding Y, Shan L, Shan X, Qian J, Zhou X, Huang Z, Zhu W, Ding Y, Cheng W, Liu P, Shu Y.
    Tumour Biol; 2015 Apr 13; 36(4):2737-45. PubMed ID: 25492481
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.